Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma.
about
Genome-editing Technologies for Gene and Cell TherapyEnabling functional genomics with genome engineeringPD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinationsMultiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition.A genome editing primer for the hematologistStable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System.An Efficient Electroporation Protocol for the Genetic Modification of Mammalian Cells.Salient Features of Endonuclease Platforms for Therapeutic Genome EditingSHP-1: the next checkpoint target for cancer immunotherapy?Genome editing: intellectual property and product development in plant biotechnology.'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations.Delivery technologies for genome editing.Increasing the safety and efficacy of chimeric antigen receptor T cell therapy.Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci.Ex vivo and in vivo genome editing: a regulatory scientific framework from early development to clinical implementation.Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment optionCRISPR-mediated genome editing and human diseases
P2860
Q26769662-482DA2DC-5D02-47DF-85EA-3DB1554F15C5Q26782747-7D5BF96A-00F4-4F82-96B3-237CEF0BB71AQ28075712-7A0149FC-06CE-4647-A5C0-93F55A970D18Q34047618-B6C23C7B-D0C6-499A-8578-55C8E3679C21Q36942027-D3D0E5FA-4AFA-4561-A097-7C6FD81B95C3Q37043492-FD6B0736-3ED0-407B-9A5E-3206FC5932CBQ37597919-3D47CEB0-9B45-4C81-B97E-EFFDD3796920Q38706622-B426585E-9023-403E-B0A8-F38523B5F893Q38805738-16D5B7FA-F521-4FF7-AD21-6EB35C06779EQ38826049-AF1E11B1-484A-4738-8F01-1546D180C112Q39136403-81A3234C-8346-49B0-8425-6114F28AD6AFQ39197557-67AA2816-95AB-4CAA-8ABD-BF9D28B54423Q39256918-50B9585C-A0B3-47CE-ADBF-4A1156EDE0FCQ47327388-DBBC7F5D-0D82-441F-9956-6060232E0D17Q48529117-33170684-9275-4F70-A6BB-1C514A35A20BQ57038247-AC3F6AB9-03E5-41A9-B093-F7B5D157C3A8Q57253681-4A10792D-6C14-4A21-9548-22FF2E900DFA
P2860
Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical Scale Zinc Finger Nuc ...... atment of Metastatic Melanoma.
@ast
Clinical Scale Zinc Finger Nuc ...... atment of Metastatic Melanoma.
@en
type
label
Clinical Scale Zinc Finger Nuc ...... atment of Metastatic Melanoma.
@ast
Clinical Scale Zinc Finger Nuc ...... atment of Metastatic Melanoma.
@en
prefLabel
Clinical Scale Zinc Finger Nuc ...... atment of Metastatic Melanoma.
@ast
Clinical Scale Zinc Finger Nuc ...... atment of Metastatic Melanoma.
@en
P2093
P2860
P50
P356
P1433
P1476
Clinical Scale Zinc Finger Nuc ...... eatment of Metastatic Melanoma
@en
P2093
Andreas Reik
Daniel Abate-Daga
David Paschon
Edward J Rebar
Jeff Miller
Martin Giedlin
Mary Black
Matthew Mendel
P2860
P304
P356
10.1038/MT.2015.71
P577
2015-05-05T00:00:00Z